Panwarfin
Drug - Panwarfin
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Warfarin Sodium
Multiple ingredients are in alphabetical order.
Strength -
10MG
The potency of the active ingredient(s), Warfarin Sodium. May repeat for multiple part products.
Applicant -
ABBOTT
The firm name holding legal responsibility for Panwarfin. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
017020
The FDA assigned number to Panwarfin. Format is nnnnnn.
Product Number -
005
The FDA assigned number to identify Panwarfin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Panwarfin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Panwarfin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Panwarfin is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of Panwarfin.
Panwarfin
|
